MK-4082 clinical trials
Also written MK-4082.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2026
How each study uses MK-4082 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- MK-4082
- 2
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
F-2 (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test MK-4082.
- Dec 2026A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)Phase 1 · Merck Sharp & Dohme LLC
Studies
Open first, then newest update. How each study uses MK-4082 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)CompletedPhase 1Merck Sharp & Dohme LLCNCT07697625Written as MK-4082
- A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)Active, not recruitingPhase 1Merck Sharp & Dohme LLCNCT07748351Written as MK-4082 Formulation 1 (F1)
- A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)CompletedPhase 1Merck Sharp & Dohme LLCNCT07388667Written as MK-4082